Virus-resistant mosquitoes to be unleashed in Colombia, Brazil

October 26, 2016

Governments and philanthropists on Wednesday announced an $18 million plan to release mosquitoes resistant to Zika, dengue and other viruses in urban areas of Colombia and Brazil.

The program aims to boost mosquito-control efforts by using Wolbachia bacteria beginning next year, following the alarming spread of the mosquito-borne Zika virus, which can cause devastating birth defects.

Wolbachia occurs naturally in 60 percent of insects, but not mosquitoes.

Research and field trials over the past several years in countries such as Australia, Indonesia and Vietnam have shown that injecting mosquitoes with the bacteria significantly reduces their ability to spread viruses to people.

Funders of the effort include USAID, the British government, the global charity Wellcome and the Bill and Melinda Gates Foundation.

"Using Wolbachia to reduce the transmission of mosquito-borne diseases has the potential to greatly reduce the global health burden and socio-economic cost of Zika and other related infections like dengue and yellow fever," said Wellcome's Mike Turner, acting director of science and head of infection and immunobiology.

"This research is essential as it will help measure the health impact of the Wolbachia method in large , where these kinds of outbreaks can have such a devastating impact."

The process of inoculating Aedes aegypti mosquitoes—which carry the viruses—with Wolbachia was developed by the Eliminate Dengue Program, a non-profit international research collaboration led by Australia's Monash University.

Small-scale field trials began in Rio de Janeiro in 2014 and Bello, Colombia—a suburb of northwestern Medellin—in 2015.

The new cash injection will "finance the rapid scale up of Wolbachia deployments in Latin America, commencing in early 2017," a statement from the funders said.

"Wolbachia coverage will be extended across Bello and other parts of Antioquia and now across parts of the greater Rio de Janeiro area."

Scientists say they will study the areas over the next two to three years to determine the impact on human health, in the hope the releases will significantly reduce new cases of Zika, dengue and chikungunya.

Explore further: Bill Gates urges UK to invest in science as Brexit looms

Related Stories

Bill Gates urges UK to invest in science as Brexit looms

October 26, 2016
US billionaire philanthropist Bill Gates urged Britain on Wednesday to step up investment in science and research as it prepares to leave the EU.

Inheritable bacterium controls Aedes mosquitoes' ability to transmit Zika

May 4, 2016
Aedes mosquitoes carrying the bacterium Wolbachia—found inside the cells of 60 percent of all insect species—are drastically less able to transmit Zika virus, say researchers at Brazil's Oswaldo Cruz Foundation (FIOCRUZ) ...

Benign bacteria block mosquitoes from transmitting Zika, chikungunya viruses

July 1, 2016
Researchers at the University of Wisconsin-Madison have confirmed that a benign bacterium called Wolbachia pipientis can completely block transmission of Zika virus in Aedes aegypti, the mosquito species responsible for passing ...

Dengue program expands outlook

December 30, 2014
Scaling up to take on large urban areas is the latest challenge for the Eliminate Dengue program, which tackles the disease by seeding infected areas with mosquitoes infected by a particular bacterium. 

A quick and easy new method to detect Wolbachia bacteria in intact Aedes mosquitoes

June 30, 2016
Aedes aegypti mosquitoes transmit dengue, chikungunya, and zika viruses. A study published in PLOS Neglected Tropical Diseases reports a new technique that could make one approach to mosquito control—using Wolbachia bacteria ...

Wolbachia parasite superinfection: A new tool to fight mosquito arbovirus transmission

February 18, 2016
Aedes aegypti mosquitoes transmit a number of pathogens, including the Dengue, Chikungunya, and Zika viruses. Wolbachia, a bacterium that naturally infects many insect species but not Aedes aegypti, can nonetheless be introduced ...

Recommended for you

Largest oral HPV study in England shows infection rates lower than expected

August 20, 2018
Infection rates of high risk human papillomavirus (HR-HPV) oral infection in England are lower than expected, compared to previous US studies.

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.